Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery

Clinical Endocrinology

Volumn 66, Issue 3, 2007, Pages 405-409

  Schott, Matthias ^a,b   Willenberg, Holger S ^a   Sagert, Cornelia ^a   Nguyen, Thi Bang Tam ^a   Schinner, Sven ^a   Cohnen, Mathias ^a   Cupisti, Kenko ^a   Eisenberger, Claus F ^a   Knoefel, Wolfram T ^a   Scherbaum, Werner A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; OCCULT CANCER; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROID SURGERY; TISSUE SECTION;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; HUMANS; LUMINESCENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASM, RESIDUAL; PENTAGASTRIN; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846936480     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02747.x     Document Type: Article

References (21)

1. Vitale, G., Caraglia, M., Ciccarelli, A., Lupoli, G., Abbruzzese, A., Tagliaferri, P. & Lupoli, G. (2001) Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer, 91, 1797-1808.
2. Samaan, N.A., Schultz, P.N. & Hickey, R.C. (1989) Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy. Hormone and Metabolic Research (Suppl.), 21, 21-25.
3. Raue, F., Kotzerke, J., Reinwein, D., Schroder, S., Roher, H.D., Deckart, H., Hofer, R., Ritter, M., Seif, F. & Buhr, H. (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clinical Investigations, 71, 7-12.
4. Barbet, J., Campion, L., Kraeber-Bodere, F. & Chatal, J.F. (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 90, 6077-6084.
5. Modigliani, E., Cohen, R., Campos, J.M., Conte-Devolx, B., Maes, B., Boneu, A., Schlumberger, M., Bigorgne, J.C., Dumontier, P., Leclerc, L., Corcuff, B. & Guilhem, I. (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients: The GETC Study Group (Groupe d'etude des tumeurs a calcitonine). Clinical Endocrinology, 48, 265-273.
6. Machens, A., Niccoli-Sire, P., Hoegel, J., Frank-Raue, K., van Vroonhoven, T.J., Roeher, H.D., Wahl, R.A., Lamesch, P., Raue, F., Conte-Devolx, B. & Dralle, H. (2003) Early malignant progression of hereditary medullary thyroid cancer. New England Journal of Medicine, 349, 1517-1525.
7. Brandt-Mainz, K., Muller, S.P., Gorges, R., Saller, B. & Bockisch, A. (2000) The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. European Journal of Nuclear Medicine, 27, 490-496.
8. Gourgiotis, L., Sarlis, N.J., Reynolds, J.C., VanWaes, C., Merino, M.J. & Pacak, K. (2003) Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. Journal of Clinical Endocrinology and Metabolism, 88, 637-641.
9. Frank-Raue, K., Raue, F., Buhr, H.J., Baldauf, G., Lorenz, D. & Ziegler, R. (1992) Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid, 2, 113-117.
10. Abdelmoumene, N., Schlumberger, M., Gardet, P., Roche, A., Travagli, J.P., Francese, C. & Parmentier, C. (1994) Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. British Journal of Cancer, 69, 1141-1144.
11. Medina-Franco, H., Herrera, M.F., Lopez, G., Tielve-Campillo, M., Sierra, M., Lozano-Salazar, R.R. & Gonzalez, O. (2001) Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin. Revista de Investigacion Clinica, 53, 212-217.
12. Cupisti, K., Simon, D., Dotzenrath, C., Goretzki, P.E. & Roher, H.D. (1997) [Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland]. Langenbecks Archivs Fur Chirurgie, 382, 295-301.
13. Auffermann, W., Clark, O.H., Thurnher, S., Galante, M. & Higgins, C.B. (1988) Recurrent thyroid carcinoma: characteristics on MR images. Radiology, 168, 753-757.
14. Baudin, E., Lumbroso, J., Schlumberger, M., Leclere, J., Giammarile, F., Gardet, P., Roche, A., Travagli, J.P. & Parmentier, C. (1996) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. Journal of Nuclear Medicine, 37, 912-916.
15. Krenning, E.P., Kwekkeboom, D.J., Bakker, W.H., Breeman, W.A., Kooij, P.P., Oei, H.Y., van Hagen, M., Postema, P.T., de Jong, M. & Reubi, J.C.& (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. European Journal of Nuclear Medicine, 20, 716-731.
16. Eising, E.G., Farahati, J., Bier, D., Knust, E.J. & Reiners, C. (1995) [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors]. Nuklearmedizin, 34, 1-7.
17. Frank-Raue, K., Bihl, H., Dorr, U., Buhr, H., Ziegler, R. & Raue, F. (1995) Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clinical Endocrinology, 42, 31-37.
18. Reiners, C. (1992) Imaging methods for medullary thyroid cancer. Recent Results in Cancer Research, 125, 125-145.
19. Juweid, M., Sharkey, R.M., Behr, T., Swayne, L.C., Rubin, A.D., Herskovic, T., Hanley, D., Markowitz, A., Dunn, R., Siegel, J., Kamal, T. & Goldenberg, D.M. (1996) Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. Journal of Clinical Oncology, 14, 1209-1217.
20. Juweid, M., Sharkey, R.M., Behr, T., Swayne, L.C., Herskovic, T., Pereira, M., Rubin, A.D., Hanley, D., Dunn, R., Siegel, J. & Goldenberg, D.M. (1996) Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. Journal of Nuclear Medicine, 37, 905-911.
21. Simeone, J.F., Daniels, G.H., Hall, D.A., McCarthy, K., Kopans, D.B., Butch, R.J., Mueller, P.R., Stark, D.D., Ferrucci, J.T. Jr & Wang, C.A. (1987) Sonography in the follow-up of 100 patients with thyroid carcinoma. American Journal of Radiology, 148, 45-49.